Anlotinib Not Yet Recruiting Phase 2 Trials for Small Cell Lung Cancer (SCLC) Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04363255First-line Chemotherapy Followed by Toripalimab Combined With Anlotinib for Maintenance in ES-SCLC